Management Plan for Alcoholic Cirrhosis
Complete abstinence from alcohol is the cornerstone of treatment for alcoholic cirrhosis and represents the most important therapeutic goal to reduce the risk of complications and mortality. 1
Assessment
Clinical Evaluation
- Assess for complications of cirrhosis:
Laboratory and Imaging Studies
- Complete blood count, liver function tests, coagulation profile
- MELD score calculation for prognosis and transplant listing consideration 1
- Abdominal ultrasound with Doppler to assess for portal hypertension
- Screening for hepatocellular carcinoma (HCC) as per standard cirrhosis protocols 1
- Risk increases from 7-16% after 5 years to 29% after 10 years 1
Screening for Alcohol-Related Damage to Other Organs
- Cardiac assessment (alcoholic cardiomyopathy) 1
- Renal function (IgA-induced nephropathy) 1
- Neurological evaluation (central and peripheral involvement) 1
- Pancreatic function (chronic pancreatitis) 1
- Cognitive assessment for alcoholic dementia, withdrawal syndrome, and Wernicke's encephalopathy 1
Nutritional Assessment
- Evaluate for malnutrition (common in alcoholic cirrhosis) 1
- Consider dietitian consultation in severe cases 1
Treatment Plan
1. Alcohol Abstinence
- Complete and permanent cessation of alcohol consumption 1
2. Management of Alcohol Use Disorder
- Refer to addiction specialists for comprehensive treatment 1
- Consider pharmacotherapy for alcohol use disorder:
- Implement psychosocial support and motivational therapy 1, 3
3. Nutritional Support
- Provide aggressive nutritional therapy rich in calories and proteins 1
- Supplement with vitamins and micronutrients 1
- Consider enteral nutrition in severely malnourished patients 1
4. Management of Cirrhosis Complications
Ascites Management
- Sodium restriction (2000 mg/day) 1
- Diuretic therapy (spironolactone with or without furosemide) 1
- Paracentesis for refractory or tense ascites
- Avoid fluid restriction unless severe hyponatremia (sodium <120-125 mmol/L) 1
Portal Hypertension
- Primary and secondary prophylaxis for variceal bleeding
- Beta-blockers for patients with varices
- Endoscopic band ligation when indicated
Hepatic Encephalopathy
- Identify and treat precipitating factors
- Lactulose and/or rifaximin therapy
Hepatocellular Carcinoma Surveillance
- Ultrasound examination every 6 months 1
5. Management of Cofactors
- Identify and treat:
6. Liver Transplantation Evaluation
- Consider for decompensated cirrhosis 1, 6
- Most programs require 6-month abstinence period prior to evaluation 1
- Survival rates post-transplant for alcoholic liver disease are comparable to other etiologies 1
Prognosis
- 1-year and 5-year mortality risks are approximately 30% and 60%, respectively 1
- Hepatic encephalopathy is associated with highest mortality among complications 1
- Continued alcohol consumption is the most important factor increasing risk of complications and death 1, 2
- Abstinence can lead to dramatic improvement in the reversible component of alcoholic liver disease 1
Common Pitfalls to Avoid
- Failing to screen for HCC (required even with abstinence)
- Overlooking nutritional deficiencies
- Not addressing alcohol use disorder as a separate medical condition requiring specific treatment
- Using disulfiram for alcohol use disorder in patients with liver disease 1, 4
- Neglecting to evaluate for alcohol-related damage to other organ systems
- Assuming low levels of alcohol consumption are safe (they are not) 2
- Underutilizing medications for alcohol use disorder which can improve survival 5
Bold text indicates the most important recommendation.